Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2–Associated Vestibular Schwannomas A randomized phase II trial comparing the PD-L1 inhibitor ...
Core immunopathological mechanisms of irAEs: Dysregulation of immune cells and cytokines. Credit must be given to the creator.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback